DC Field | Value | Language |
dc.contributor.author | Bondarenko, Anastasiia | |
dc.contributor.author | Lishchuk-Yakymovych, Khrystyna | |
dc.contributor.author | Stepanovskyi, Yu. | |
dc.contributor.author | Zabrodska, L. | |
dc.date.accessioned | 2025-09-29T07:39:55Z | |
dc.date.available | 2025-09-29T07:39:55Z | |
dc.date.issued | 2025 | |
dc.identifier.citation | BONDARENKO, Anastasiia; Khrystyna LISHCHUK-YAKYMOVYCH; Yu. STEPANOVSKYI; L. ZABRODSKA. Hereditary angioedema in Ukraine: clinical manifestation and diagnostic features. In: Conferinţă internaţională "Pediatria fără frontiere", 30-31 mai 2025, Chișinău, Republica Moldova: [rezumate]. Chişinău, 2025, p. 131. ISBN 978-5-85748-167-7. | en_US |
dc.identifier.isbn | 978-5-85748-167-7 | |
dc.identifier.uri | https://ibn.idsi.md/vizualizare_articol/230838 | |
dc.identifier.uri | https://repository.usmf.md/handle/20.500.12710/31187 | |
dc.description.abstract | Introduction. Hereditary angioedema (HAE) is a rare disease associated by
bradikinin-mediated episodes of edema. Lack of diagnostic tools and treatment
options until 2020 led to a small number of diagnosed patients in Ukraine. In
2020 treatment with C1 inhibitor became available to Ukrainian patients at the
expense of the state budget.
Methods. Purpose is to summarise the data about HAE diagnostics and clinical
manifestation in Ukraine. The diagnosis of HAE was based on double results of
low C1-inhibitor concentration and/or activity or genetic testing for C1-normal
HAE. The data are based on the reports of clinical immunologists all over
Ukraine and questionnaires distributed among patient organization members.
Results. To date, 140 patients with HAE (115 - type 1, 24 - type 2, 1 - normal
C1- inhibitor) have been diagnosed in Ukraine, of which 114 are adults and 28
are children, 62.6% of patients were diagnosed during 2021-2025 since the
laboratory diagnostic tools and treatment became available. Median age of
diagnosed patients іs 37,5 years (range: 6-72). In most patients, the disease
manifestated in childhood (average age 10.4 years), while the average age of
diagnosis is 26.5 years. As the first manifestation of the disease, 30% of
patients noted recurrent abdominal pain in childhood, 60% indicated edema of
the upper and lower extremities in adolescence, in 8% the disease manifested
with edema of the larynx at different ages, rare manifestations were also noted,
such as edema of the joint and breast. About 80% of patients were previously
mistakenly diagnosed as allergic angioedema. 77% have a burdened family
history for recurrent angioedema and 23% are the only member in their family.
Conclusion. Over the past few years, the diagnosis of HAE has significantly
improved in Ukraine, although the actual number is still lower the estimated
number 800 patients. The delay in diagnosis is about 16 years. Alertness about
HAE in childhood with an accent to recurrent unexplained abdominal pain is an
unused reserve for shortening the path from manifestation to diagnosis. | en_US |
dc.publisher | Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova | en_US |
dc.relation.ispartof | Materialele Conferinţei Internaţionale "Pediatria fără frontiere", 30-31 mai 2025, Chișinău, Republica Moldova | en_US |
dc.title | Hereditary angioedema in Ukraine: clinical manifestation and diagnostic features | en_US |
dc.type | Other | en_US |
Appears in Collections: | Conferinţă internaţională "Pediatria fără frontiere", 30-31 mai 2025, Chișinău, Republica Moldova: [rezumate]
|